Carregant...

Comparison of Different Promoter Methylation Assays in Breast Cancer

Background: Promoter hypermethylation has emerged as a promising cancer biomarker. Currently, a large variety of quantitative and non-quantitative techniques is used to measure methylation in clinical specimens. Here we directly compared three commonly used methylation assays and assessed the influe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Anal Cell Pathol (Amst)
Autors principals: Suijkerbuijk, Karijn P. M., Pan, Xiaojuan, van der Wall, Elsken, van Diest, Paul J., Vooijs, Marc
Format: Artigo
Idioma:Inglês
Publicat: IOS Press 2010
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4605677/
https://ncbi.nlm.nih.gov/pubmed/20978321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/ACP-CLO-2010-0542
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!